Ligand validation:6XYT

LFA: EICOSANE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6XYT_LFA_C_309	41%	100%	0.165	0.878	0.07	0.05	-	-	0	0	100%	1
6XYT_LFA_D_410	31%	100%	0.152	0.821	0.07	0.05	-	-	0	0	100%	1
6XYT_LFA_A_311	23%	99%	0.145	0.894	0.13	0.11	-	-	0	0	30%	0.3
6XYT_LFA_E_312	23%	88%	0.151	0.918	0.24	0.43	-	-	0	0	20%	0.2
6XYT_LFA_D_409	15%	100%	0.196	0.759	0.08	0.03	-	-	1	0	100%	1
6XYT_LFA_E_313	10%	95%	0.204	0.845	0.16	0.22	-	-	0	0	25%	0.25
6XYT_LFA_C_308	8%	99%	0.202	0.789	0.13	0.09	-	-	0	0	40%	0.4
6XYT_LFA_A_307	7%	99%	0.234	0.805	0.13	0.07	-	-	0	0	35%	0.35
6XYT_LFA_D_411	6%	100%	0.22	0.764	0.1	0.07	-	-	0	0	40%	0.4
6XYT_LFA_E_311	5%	100%	0.215	0.673	0.09	0.06	-	-	0	0	70%	0.7
6XYT_LFA_D_412	5%	100%	0.433	0.868	0.09	0.08	-	-	3	0	85%	0.85
6XYT_LFA_B_307	4%	100%	0.306	0.789	0.11	0.06	-	-	1	0	45%	0.45
6XYT_LFA_B_308	4%	100%	0.231	0.71	0.11	0.08	-	-	0	0	40%	0.4
6XYT_LFA_A_310	3%	87%	0.356	0.849	0.26	0.43	-	-	0	0	20%	0.2
6XYT_LFA_E_310	3%	99%	0.232	0.672	0.12	0.09	-	-	0	0	40%	0.4
6XYT_LFA_B_309	3%	99%	0.196	0.615	0.11	0.09	-	-	0	0	50%	0.5
6XYT_LFA_D_413	3%	99%	0.211	0.652	0.13	0.07	-	-	0	0	35%	0.35
6XYT_LFA_A_308	2%	100%	0.206	0.583	0.13	0.06	-	-	0	0	40%	0.4
6XYT_LFA_D_414	1%	99%	0.387	0.743	0.12	0.09	-	-	0	0	30%	0.3
6XYT_LFA_A_312	1%	100%	0.471	0.735	0.08	0.06	-	-	0	0	80%	0.8
6XYT_LFA_C_307	1%	100%	0.362	0.685	0.12	0.06	-	-	3	0	35%	0.35
6XYT_LFA_B_310	1%	100%	0.25	0.566	0.11	0.08	-	-	0	0	35%	0.35
6XYT_LFA_A_309	1%	100%	0.265	0.565	0.1	0.07	-	-	0	0	40%	0.4
6XYT_LFA_A_316	0%	98%	0.527	0.45	0.14	0.12	-	-	0	0	45%	0.45
6RF6_LFA_A_307	50%	79%	0.101	0.904	0.23	0.62	-	-	0	0	70%	0.7
4XTL_LFA_A_315	46%	89%	0.079	0.949	0.26	0.38	-	-	1	0	25%	0.25
4XTN_LFA_J_311	43%	74%	0.092	0.958	0.38	0.61	-	-	1	0	20%	0.2
6RFC_LFA_A_336	39%	87%	0.105	0.92	0.24	0.46	-	-	0	0	40%	0.4
6YC3_LFA_C_313	39%	100%	0.159	0.866	0.07	0.04	-	-	1	0	100%	1
6SU4_LFA_X_616	66%	100%	0.113	0.917	0.09	0.1	-	-	0	0	100%	1
7AKY_LFA_A_403	58%	99%	0.088	0.911	0.08	0.14	-	-	5	0	75%	0.75
8QLF_LFA_A_408	56%	100%	0.083	0.933	0.1	0.06	-	-	1	0	55%	0.55
4HYJ_LFA_B_302	48%	74%	0.164	0.962	0.2	0.79	-	-	1	0	70%	0.7
7Z09_LFA_A_801	40%	76%	0.087	0.914	0.37	0.58	-	-	1	0	35%	0.35

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.